Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lechat

Showing results (311-320 of 318) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 318 results.
The American Journal of Cardiology|April 24, 1999
Different effects of bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (a 24-hour Holter substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS])R L Anthonio, J Brouwer, P Lechat, et al.
The Journal of Endocrinology|January 1, 1996
Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failureC Azizi, G Maistre, H Kalotka, et al.
Clinical Pharmacology and Therapeutics|April 24, 2008
Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategyC Lebaudy, J S Hulot, Z Amoura, et al.
Circulation|October 23, 1997
Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS)P Lechat, S Escolano, J L Golmard, et al.
Circulation|December 29, 2005
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in miceA Mekontso-Dessap, F Brouri, O Pascal, et al.
Therapie|July 1, 1996
First Congress of the European Association for Clinical Pharmacology and TherapeuticsC Advenier, B Avouac, P Bechtel, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 20, 2001
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS)P Lechat, H Lardoux, A Mallet, et al.
Therapie|March 10, 2001
[Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)]P Lechat, H Lardoux, A Mallet, et al.
Pageof 32

Showing results (311-320 of 318) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 318 results.
The American Journal of Cardiology|April 24, 1999
Different effects of bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (a 24-hour Holter substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS])R L Anthonio, J Brouwer, P Lechat, et al.
The Journal of Endocrinology|January 1, 1996
Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failureC Azizi, G Maistre, H Kalotka, et al.
Clinical Pharmacology and Therapeutics|April 24, 2008
Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategyC Lebaudy, J S Hulot, Z Amoura, et al.
Circulation|October 23, 1997
Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS)P Lechat, S Escolano, J L Golmard, et al.
Circulation|December 29, 2005
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in miceA Mekontso-Dessap, F Brouri, O Pascal, et al.
Therapie|July 1, 1996
First Congress of the European Association for Clinical Pharmacology and TherapeuticsC Advenier, B Avouac, P Bechtel, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 20, 2001
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS)P Lechat, H Lardoux, A Mallet, et al.
Therapie|March 10, 2001
[Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)]P Lechat, H Lardoux, A Mallet, et al.
Pageof 32